The Impact of Metabolic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters on the Prognosis of Resectable Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

The Impact of Metabolic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters on the Prognosis of Resectable Pancreatic Adenocarcinoma

Published:2023-02-01 Issue:1 Volume:32 Page:35-41
ISSN:2146-1414
Container-title:Molecular Imaging and Radionuclide Therapy
language:
Short-container-title:Mirt

Author:

Ekmekçioğlu Özgül^ORCID,Battal Muharrem^ORCID,Bostancı Özgür^ORCID,Yılmaz Özgüven Banu^ORCID

Publisher

Galenos Yayinevi

Subject

Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database;Bilimoria;Cancer,2007

2. Pancreatic cancer;Li;Lancet,2004

3. Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer;Grassetto;Am J Clin Oncol,2011

4. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma;Lewis;HPB (Oxford),2013

5. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer;Ghaneh;Health Technol Assess,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluación del papel de la sarcopenia y de los parámetros de la PET/TC con [18F]FDG en el pronóstico del adenocarcinoma ductal de páncreas;Revista Española de Medicina Nuclear e Imagen Molecular;2024-09

2. Evaluating the role of sarcopenia and [18F]FDG PET/CT parameters in prognosis of pancreatic ductal adenocarcinoma;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-08

3. Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor;Journal of Clinical Medicine;2023-10-11